N. Strigl‐Pill

617 total citations
7 papers, 456 citations indexed

About

N. Strigl‐Pill is a scholar working on Organic Chemistry, Molecular Biology and Neurology. According to data from OpenAlex, N. Strigl‐Pill has authored 7 papers receiving a total of 456 indexed citations (citations by other indexed papers that have themselves been cited), including 3 papers in Organic Chemistry, 3 papers in Molecular Biology and 3 papers in Neurology. Recurrent topics in N. Strigl‐Pill's work include Glycogen Storage Diseases and Myoclonus (3 papers), Lysosomal Storage Disorders Research (3 papers) and Carbohydrate Chemistry and Synthesis (3 papers). N. Strigl‐Pill is often cited by papers focused on Glycogen Storage Diseases and Myoclonus (3 papers), Lysosomal Storage Disorders Research (3 papers) and Carbohydrate Chemistry and Synthesis (3 papers). N. Strigl‐Pill collaborates with scholars based in Germany, United Kingdom and Sweden. N. Strigl‐Pill's co-authors include Benedikt Schoser, Marcus Deschauer, Wolfgang Müller‐Felber, Stephan Wenninger, Matthias Spranger, Stefan Vielhaber, Franz X. Glocker, Cornelia Kornblum, Eugen Mengel and Max J. Hilz and has published in prestigious journals such as Journal of Neurology, European Journal of Neurology and Journal of Inherited Metabolic Disease.

In The Last Decade

N. Strigl‐Pill

7 papers receiving 448 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
N. Strigl‐Pill Germany 6 361 309 103 99 92 7 456
Carine I. van Capelle Netherlands 14 490 1.4× 408 1.3× 169 1.6× 61 0.6× 123 1.3× 18 600
Stephanie DeArmey United States 14 467 1.3× 319 1.0× 117 1.1× 48 0.5× 117 1.3× 19 573
Anne Chun-Hui Tsai United States 10 407 1.1× 284 0.9× 86 0.8× 37 0.4× 113 1.2× 11 579
K. Eger Germany 9 226 0.6× 206 0.7× 53 0.5× 127 1.3× 62 0.7× 19 464
J.H.J. Wokke Netherlands 7 303 0.8× 240 0.8× 68 0.7× 195 2.0× 79 0.9× 15 530
Johanna M. P. van den Hout Netherlands 12 634 1.8× 420 1.4× 140 1.4× 47 0.5× 145 1.6× 31 729
Claudio Semplicini Italy 17 214 0.6× 185 0.6× 71 0.7× 38 0.4× 51 0.6× 25 480
Deya Corzo United States 6 223 0.6× 145 0.5× 68 0.7× 13 0.1× 62 0.7× 10 322
Gilles Morin France 9 226 0.6× 156 0.5× 60 0.6× 11 0.1× 62 0.7× 22 463
C. Iturriaga Spain 8 195 0.5× 49 0.2× 57 0.6× 24 0.2× 64 0.7× 8 464

Countries citing papers authored by N. Strigl‐Pill

Since Specialization
Citations

This map shows the geographic impact of N. Strigl‐Pill's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by N. Strigl‐Pill with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites N. Strigl‐Pill more than expected).

Fields of papers citing papers by N. Strigl‐Pill

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by N. Strigl‐Pill. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by N. Strigl‐Pill. The network helps show where N. Strigl‐Pill may publish in the future.

Co-authorship network of co-authors of N. Strigl‐Pill

This figure shows the co-authorship network connecting the top 25 collaborators of N. Strigl‐Pill. A scholar is included among the top collaborators of N. Strigl‐Pill based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with N. Strigl‐Pill. N. Strigl‐Pill is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

7 of 7 papers shown
1.
Wenninger, Stephan, et al.. (2012). Toward deconstructing the phenotype of late‐onset Pompe disease. American Journal of Medical Genetics Part C Seminars in Medical Genetics. 160C(1). 80–88. 83 indexed citations
2.
Kornblum, Cornelia, Frank Hanisch, Stefan Vielhaber, et al.. (2012). 36 months observational clinical study of 38 adult Pompe disease patients under alglucosidase alfa enzyme replacement therapy. Journal of Inherited Metabolic Disease. 35(5). 837–845. 99 indexed citations
3.
Reilich, Peter, Nicolai Schramm, Benedikt Schoser, et al.. (2010). Facioscapulohumeral muscular dystrophy presenting with unusual phenotypes and atypical morphological features of vacuolar myopathy. Journal of Neurology. 257(7). 1108–1118. 20 indexed citations
4.
Strigl‐Pill, N., Cornelia Kornblum, K. Eger, et al.. (2009). Enzyme replacement therapy with alglucosidase alfa in 44 patients with late-onset glycogen storage disease type 2: 12-month results of an observational clinical trial. Journal of Neurology. 257(1). 91–97. 196 indexed citations
5.
Schara, Ulrike, Nina Barišić, Marcus Deschauer, et al.. (2009). Ephedrine therapy in eight patients with congenital myasthenic syndrome due to DOK7 mutations. Neuromuscular Disorders. 19(12). 828–832. 41 indexed citations
6.
Schara, Ulrike, Marcus Deschauer, Matthias Wendt, et al.. (2007). G.P.10.03 Therapeutic effects of ephedrine in congenital myasthenic syndrome due to DOK7 mutations. Neuromuscular Disorders. 17(9-10). 818–819. 1 indexed citations
7.
Strigl‐Pill, N., et al.. (2006). Prediction of response to IVIg treatment in patients with lower motor neurone disorders. European Journal of Neurology. 13(2). 135–140. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026